Tavegil (clemastine) / GSK  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tavegil (clemastine) / GSK
NCT00913549: To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets

Completed
1
36
NA
Clemastine Fumarate Tablets, 2.68 mg (Cord Laboratories), Tavist Tablets, 2.68 mg (Sandoz Pharmaceutical Corp.)
Sandoz
Allergy
01/90
01/90
NCT02613091: Effect of Clemastine Fumarate on Color Vision in Healthy Controls

Completed
1
23
US
Clemastine fumarate
University of California, San Francisco
Healthy Subjects
09/16
 

Download Options